To deliver these therapies to the patients who need them, their success hinges on effective storage and management to maintain integrity throughout their lifecycle. From early development to commercialization, safeguarding sensitive biological materials demands scalable storage solutions and meticulous risk mitigation strategies. Partnering with a CDMO specializing in ultracold storage and biorepository management is critical to preserving product integrity and ensuring continuity throughout every development stage. This webinar will explore how the right CDMO partner can streamline biological material storage, mitigate risks, and provide the scalability needed to support growth from clinical trials to commercial launch, empowering you to advance your pipeline with confidence. Participants will gain insight into:

Traditional payment methods negatively impact clinical trial participation, with over 50% failing to meet recruitment targets due to payment issues. To increase recruitment and retention, sponsors must adopt flexible, accessible, and user-friendly payment solutions. Gain expert insights on the payment landscape, including:

Financial burdens are cited as one of the main barriers to clinical trial recruitment and retention, with traditional methods proving unreliable, complicated and slow. For trial sites and sponsors, the administration burden can be overwhelming, especially on a global scale. Discover how IQVIA’s Participant Payment service is transforming the participant payment landscape, simplifying the process and driving clinical trial success, by offering:

The field of precision medicine is rapidly evolving, enabling the development of innovative therapies highly tailored to individuals’ genetic profiles - resulting in revolutionized treatments and improved patient outcomes. Discover expert insights on the current landscape of personalized medicine, including the opportunities and challenges, including:

Lyophilization – or freeze drying – offers a manufacturing solution for sensitive biopharmaceuticals and vaccines that would otherwise have to rely heavily on complex cold-chain logistics during storage and transport. In this webinar recording, an expert from Thermo Fisher Scientific shares his perspectives on the value and challenges of lyophilization. Watch on demand to gain a deeper understanding of:

The use of lyophilization – or freeze drying – in the pharma manufacturing process is central to ensuring the stability and efficacy of biopharmaceuticals and vaccines for patients worldwide. Navigating the complexities of lyophilization can be tricky, and partnering with the right CDMO service providers to ensure compliance and scale-up readiness is essential. Explore the key considerations in lyophilization, with insights into:

CDMO quality performance impacts all measures of product success and improvement. Explore the key indicators of CDMO quality performance to understand its key influence on crucial aspects of pharmaceutical manufacturing. Learn how quality can accelerate time to market, reduce risk, improve return on investment, and ensure the safety and efficacy of medicines. Capture new insights into:

Changing delivery formats for sterile injectable therapies can be a valuable strategy for effectively managing the lifecycle of a drug, helping bring it to market faster, make it usable in more situations, provide cost efficiencies for the supplier, and ease medication administration to patients. Explore the considerations in making the switch, in your free white paper. Learn more about the factors in transferring delivery formats, including:

Make your successful technology transfer a reality by applying these nine key principles. Whether you are scaling up drug production, relocating to a new facility, or transitioning to a new outsourcing partner, these essential steps will help you build a plan that drives efficiency and ensures reliability – all while keeping costs down. View the infographic now to explore the critical elements for technology transfer, including: